Chapter 5 │ Page 196 108. Q. Chi, Z-Y. Wang, H-Y. Li, D-B. Song, H. Xu, G. Ma, Z-M. Wang, X-M. Li, Tumorsuppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin, Chin. Med. J. (Engl.) 132 (2019) 2354-2361. 109. Y. Kou, L-Y. Ji, H-J. Wang, W-S. Wang, H-M. Zheng, J. Zou, L-X. Liu, X-X. Qi, Z-Q. Liu, B-Y. Du, L-L. Lu, Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization, Int. J. Cancer 141 (2017) 16901703. 110. H. Wang, L. Tian, J. Liu, A. Goldstein, I. Bado, W-J. Zhang, B. R. Arenkiel, Z-H. Li, M. Yang, S-Y. Dlo, H. Zhao, D. R. Rowley, S. T. C. Wong, Z. Gugala, X. H-F. Zhang, The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability, Cancer Cell 34 (2018) 823-839. 111. Y. Wang, W. Wang, X. Wu, C. Li, Y. Huang, H. Zhou, Y. Cui, Resveratrol Sensitizes Colorectal Cancer Cells to Cetuximab by Connexin 43 Upregulation-Induced Akt Inhibition, Front. Oncol. 10 (2020) 383. 112. S. Crespin, G. Fromont, M. Wager, P. Levillain, L. Cronier, A. Monvoisin, N. Defamie, M. Mesnil, Expression of a gap junction protein, connexin43, in a large panel of human gliomas: New insights, Cancer Med. 5 (2016) 1742-1752. 113. K. D. de Oliveira, M. V. Tedardi, B. Cogliati, M. L. Dagli, Higher incidence of lung adenocarcinomas induced by DMBA in connexin 43 heterozygous knockout mice, Biomed. Res. Int. 2013 (2013) 618475. 114. M. Luo, Y. Luo, N. Mao, G. Huang, C. Teng, H. Wang, J. Wu, X. Liao, J. Yang, CancerAssociated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication, Cell Physiol. Biochem. 51 (2018) 315-336. 115. S. Fukuda, M. Akiyama, Y. Niki, R. Kawatsura, H. Harada, K-I. Nakahama, Inhibitory e ects of miRNAs in astrocytes on C6 glioma progression via connexin 43, Mol. Cell. Biochem. 476 (2021) 2623-2632. 116. S. R. Johnstone, M. Billaud, A. W. Lohman, E. P. Taddeo, B. E. Isakson, Posttranslational modifications in connexins and pannexins, J. Membr. Biol. 245 (2012) 319-332. 117. H. Fukumasu, J. L. Avanzo, D. S. Sanches, G. Mennecier, C. M. C. Mori, M. L. Z. Dagli, Higher susceptibility of spontaneous and NNK-induced lung neoplasms in connexin 43 deficient CD1 x AJ F1 mice: paradoxical expression of connexin 43 during lung carcinogenesis, Mol. Carcinog. 52 (2013) 497-506. 118. S. Lee and C. A. Schmitt, Chemotherapy response and resistance, Curr. Opin. Genetics & Development 13 (2003) 90-96. 119. S. Wang, S. Zhang, Z. Zhao, C. Zhang, X. Yang, Y. Wang, Connexin 43 enhances paclitaxel cytotoxicity in colorectal cancer cell lines, Exp. Ther. Med. 14 (2017) 12121218. 120. D-P. Wu, Y. Zhou, L-X. Hou, X-X. Zhu, W. Yi, S-M. Yang, T-Y. Lin, J-L. Huang, B. Zhang, XX. Yin, Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway, Int. J. Biol. Sci. 17 (2021) 2380-2398. 121. X. Xu, V. M. Berthoud, E. C. Beyer, L. Ebihara, Functional Role of the Carboxyl Terminal Domain of Human Connexin 50 in Gap Junctional Channels, J. Membr. Biol. 186 (2002) 101-112.
RkJQdWJsaXNoZXIy MTk4NDMw